Overview: Methylmalonic Acid Qualitative TestIntroduction: The Methylmalonic Acid Qualitative Test detects methylmalonic acid to diagnose vitamin B12 deficiency, causing fatigue or neurological issues. Following 2023 ASH guidelines, it uses biochemistry methods for high specificity, supporting metabolic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected vitamin B12 deficiency.
Other Names: MMA Qualitative Assay, Vitamin B12 Deficiency Screen.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: MMA testing began in the 1960s with metabolic research. Qualitative methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects methylmalonic acid to diagnose vitamin B12 deficiency, guides treatment, and evaluates patients with fatigue or neurological issues.
Test Parameters: 1. Methylmalonic Acid (Qualitative)
Pretest Condition: No fasting required. Collect urine. Report history of fatigue, neurological issues, or dietary deficiencies.
Specimen: Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, neurological issues, anemia, or history of vegetarian/vegan diet. Include current medications, especially proton pump inhibitors.
Consent: Written consent required, detailing the tests purpose, vitamin B12 deficiency implications, and risks of urine collection.
Procedural Considerations: Uses biochemistry methods (e.g., gas chromatography) to detect methylmalonic acid in urine. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for vitamin B12 deficiency screening.
Factors Affecting Result Accuracy: Contamination or improper sample storage can affect results. Dilute urine may reduce sensitivity.
Clinical Significance: Positive methylmalonic acid detection suggests vitamin B12 deficiency, guiding supplementation. Negative results may require quantitative testing.
Specialist Consultation: Consult a hematologist or primary care physician for result interpretation and treatment planning.
Additional Supporting Tests: Serum B12, homocysteine, or CBC to confirm vitamin B12 deficiency diagnosis.
Test Limitations: Qualitative test may miss low-level deficiencies; clinical correlation is needed. Dietary factors affect results.
References: ASH B12 Deficiency Guidelines, 2023; Blood, Carmel R, 2022.
